Showing results (111-120 of 176) with videos related to
Sort By:
Pageof 18
NPJ Precision Oncology|April 18, 2026
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategiesRiccardo Bevilacqua, Paola Gasperini, Thomas Cantore, et al.JAMA Oncology|July 17, 2015
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment ResponseHimisha Beltran, Kenneth Eng, Juan Miguel Mosquera, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohortLorelei A Mucci, Yudi Pawitan, Francesca Demichelis, et al.Nature Communications|April 18, 2023
Bladder cancer organoids as a functional system to model different disease stages and therapy responseMartina Minoli, Thomas Cantore, Daniel Hanhart, et al.Cancer Discovery|June 13, 2025
Germline-somatic liaison dictates cancer subtype via de novo steroid biosynthesisPaola Gasperini, Alessandro Alaimo, Blerta Stringa, et al.International Journal of Cancer|October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patientsVincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.NAR Cancer|June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assayFrancesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.NPJ Genomic Medicine|August 8, 2017
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer careHanna Rennert, Kenneth Eng, Tuo Zhang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancerSunita R Setlur, Chen X Chen, Ruhella R Hossain, et al.Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.Pageof 18